GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Marsh & McLennan Companies Inc (NYSE:MMC) » Definitions » EPS without NRI

Marsh & McLennan (Marsh & McLennan) EPS without NRI

: $8.17 (TTM As of Mar. 2024)
View and export this data going back to 1969. Start your Free Trial

Marsh & McLennan's earnings per share without non-recurring items for the three months ended in Mar. 2024 was $2.82. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was $8.17.

During the past 12 months, Marsh & McLennan's average earnings per share (NRI) Growth Rate was 33.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 26.20% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 17.70% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Marsh & McLennan's EPS without NRI or its related term are showing as below:

MMC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -34.8   Med: 9.1   Max: 43.5
Current: 26.2

During the past 13 years, Marsh & McLennan's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 43.50% per year. The lowest was -34.80% per year. And the median was 9.10% per year.

MMC's 3-Year EPS without NRI Growth Rate is ranked better than
73.15% of 406 companies
in the Insurance industry
Industry Median: 9.1 vs MMC: 26.20

Marsh & McLennan's EPS (Diluted) for the three months ended in Mar. 2024 was $2.82. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $7.88.

Marsh & McLennan's EPS (Basic) for the three months ended in Mar. 2024 was $2.84. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $7.94.


Marsh & McLennan EPS without NRI Historical Data

The historical data trend for Marsh & McLennan's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marsh & McLennan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.44 3.97 6.04 6.01 7.99

Marsh & McLennan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.47 2.20 1.47 1.68 2.82

Competitive Comparison

For the Insurance Brokers subindustry, Marsh & McLennan's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marsh & McLennan PE Ratio without NRI Distribution

For the Insurance industry and Financial Services sector, Marsh & McLennan's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Marsh & McLennan's PE Ratio without NRI falls into.



Marsh & McLennan EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marsh & McLennan  (NYSE:MMC) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Marsh & McLennan EPS without NRI Related Terms

Thank you for viewing the detailed overview of Marsh & McLennan's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Marsh & McLennan (Marsh & McLennan) Business Description

Address
1166 Avenue of the Americas, New York, NY, USA, 10036-2774
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the U.S.
Executives
Oscar Fanjul director C/O OMEGA CAPITAL, S.L., PASEO DE LA CASTELLANA, 28, MADRID U3 28046
John Jude Jones officer: Chief Marketing Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Dean Michael Klisura officer: President & CEO, Guy Carpenter 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Steven A Mills director IBM CORPORATION, 294 ROUTE 100, SOMERS NY 10589
Mark C Mcgivney officer: Chief Financial Officer
Judith Hartmann director 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Ray G Young director 77 WEST WACKER DR., SUITE 4600, CHICAGO IL 60601
Stacy Mills officer: Vice President and Controller C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENENUE OF THE AMERICAS, NEW YORK NY 11102
Paul Beswick officer: SVP, Chief Information Officer 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martin South officer: President & CEO, Marsh 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Martine Ferland officer: President and CEO, Mercer C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Katherine Brennan officer: SVP and General Counsel 1166 AVENUE OF THE AMERICAS, 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Daniel S Glaser officer: Chairman & CEO, Marsh C/O MARSH & MCLENNAN COMPANIES, INC., 1166 AVENUE OF THE AMERICAS, NEW YORK NY 10036
Hafize Gaye Erkan director 727 FIFTH AVENUE, NEW YORK NY 10022
Marc D Oken director C/O FALFURRIAS CAPITAL PARTNERS, 100 N. TRYON STREET, SUITE 5120, CHARLOTTE NC 28202

Marsh & McLennan (Marsh & McLennan) Headlines